About METOIMMUNE LLC
MetoImmune LLC is a start-up biotech company founded in 2023 that is developing an active immunization against Alzheimer’s disease using a methionine-sulfoxide (MetO)-rich protein antigen. The company is advancing this therapy into pre-clinical and clinical trials and is also developing a blood-plasma test for early detection of AD.
Development of active immunization against Alzheimer’s diseasePre-clinical and clinical trial advancementDevelopment of a blood-plasma test for early detection of Alzheimer’s disease
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to METOIMMUNE LLC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.